carmustine
Ligand Summary
A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
UNII: U68WG3173Y
PubChem: 2578
ChEMBL: CHEMBL513
DrugCentral: 512
LyCHI: BDR6KT81M7WL
Target Activities
1 Activities
Items per page:
10
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | INHIBITOR | |||||